Trial Information
Current as of August 11, 2025
Active, not recruiting
Keywords
ClinConnect Summary
The Syndesmosis Ankle Study is examining how soon patients can safely start putting weight on their ankle after surgery for a specific type of ankle fracture known as syndesmotic disruption. Traditionally, doctors have recommended waiting for about 6 weeks before bearing weight on the injured ankle, but this study is testing whether patients can begin to walk on it just 2 weeks after surgery. The goal is to see if early weight bearing affects recovery and healing in the same way as waiting longer.
To participate in this trial, you need to be at least 18 years old and have an ankle fracture that will be treated with a specific surgical technique called suture button fixation. If you qualify, you will be randomly assigned to either start walking on your ankle after 2 weeks or to wait 6 weeks before doing so. Throughout the study, researchers will check on your progress, including your pain levels and how well your ankle is healing. This information will help doctors better understand the best practices for treating this type of injury in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years of age or older
- • 2. Ankle fracture with suspected syndesmotic disruption that would likely be treated with suture button fixation operative intervention
- • 3. Ability to ambulate preoperatively
- Exclusion Criteria:
- • 1. Younger than 18
- • 2. Length unstable syndesmotic injury (i.e. Maisonneuve)
- • 3. Neuropathic diabetics
- • 4. 325 pounds or more
- • 5. Prisoner
- • 6. Pregnant or lactating
- • 7. End stage renal disease
- • 8. Inability to follow commands (dementia, TBI, etc.)
- • 9. Polytrauma patients
About Kyle Schweser Md
Kyle Schweser, MD, is a dedicated physician and clinical trial sponsor with a focus on advancing medical research and improving patient outcomes. With extensive experience in clinical practice and a commitment to evidence-based medicine, Dr. Schweser leads innovative trials aimed at exploring novel therapeutic approaches. His expertise encompasses a range of medical disciplines, and he prioritizes collaboration with regulatory bodies, research institutions, and healthcare professionals to ensure the highest standards of safety and efficacy in clinical studies. Dr. Schweser is passionate about bridging the gap between research and clinical application, fostering advancements that enhance patient care and treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, Missouri, United States
Columbia, Missouri, United States
Patients applied
Trial Officials
Kyle Schweser, MD
Principal Investigator
University of Missouri Health System, Department of Orthopaedic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials